Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells Through Downregulation of Akt

Journal of Cancer - Australia
doi 10.7150/jca.2.435
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher